Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -110.13M
March 31, 2026 7.734M
December 31, 2025 -50.34M
September 30, 2025 -24.06M
June 30, 2025 -143.35M
March 31, 2025 -29.64M
December 31, 2024 -214.45M
September 30, 2024 -115.67M
June 30, 2024 -16.49M
March 31, 2024 -22.05M
December 31, 2023 -8.343M
September 30, 2023 -9.253M
June 30, 2023 -142.90M
March 31, 2023 -14.86M
December 31, 2022 -17.33M
September 30, 2022 -16.77M
June 30, 2022 -13.43M
March 31, 2022 -9.868M
December 31, 2021 -14.61M
September 30, 2021 -7.294M
June 30, 2021 -8.912M
March 31, 2021 -6.348M
December 31, 2020 -21.87M
September 30, 2020 -9.365M
June 30, 2020 -12.65M
Date Value
March 31, 2020 -14.76M
December 31, 2019 -20.57M
September 30, 2019 -39.11M
June 30, 2019 -53.75M
March 31, 2019 -21.05M
December 31, 2018 -196.05M
September 30, 2018 -20.31M
June 30, 2018 -45.15M
March 31, 2018 -117.32M
December 31, 2017 -11.82M
September 30, 2017 -61.27M
June 30, 2017 -15.37M
March 31, 2017 -58.30M
December 31, 2016 -12.31M
September 30, 2016 -102.88M
June 30, 2016 -12.04M
March 31, 2016 -31.88M
December 31, 2015 -11.32M
September 30, 2015 -24.23M
June 30, 2015 -17.06M
March 31, 2015 -9.411M
December 31, 2014 -9.617M
September 30, 2014 -5.516M
June 30, 2014 -11.95M
March 31, 2014 -9.123M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. -129.05M
Baxter International, Inc. -117.00M
DexCom, Inc. 329.80M
Haemonetics Corp. -22.23M
ICU Medical, Inc. -20.14M